Safety of hepatitis C virus (HCV)-treated donors for kidney transplantation excluding occult HCV infection through kidney biopsies
Rosana Gelpi
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorCamino Rodríguez-Villar
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorDavid Paredes
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorRebeca Roque
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorAngel Ruiz
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorRamon Adalia
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorErika de Sousa
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorIgnacio Revuelta
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorManuel Sole
Pathology Department, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorMiguel Martinez
Department of Clinical Microbiology, Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain
Search for more papers by this authorMireia Navarro
Department of Clinical Microbiology, Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain
Search for more papers by this authorSabela Lens
Liver Unit, IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain
Search for more papers by this authorFederico Oppenheimer
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorFritz Diekmann
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorRosana Gelpi
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorCamino Rodríguez-Villar
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorDavid Paredes
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorRebeca Roque
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorAngel Ruiz
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorRamon Adalia
Donation and Transplant Coordination Section, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorErika de Sousa
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorIgnacio Revuelta
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorManuel Sole
Pathology Department, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorMiguel Martinez
Department of Clinical Microbiology, Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain
Search for more papers by this authorMireia Navarro
Department of Clinical Microbiology, Barcelona Centre for International Health Research (CRESIB), Barcelona, Spain
Search for more papers by this authorSabela Lens
Liver Unit, IDIBAPS, CIBEREHD, University of Barcelona, Barcelona, Spain
Search for more papers by this authorFederico Oppenheimer
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorFritz Diekmann
Renal Transplant Unit, Hospital Clinic de Barcelona, University of Barcelona, Barcelona, Spain
Search for more papers by this authorConflicts of interest
The authors have declared no conflicts of interest.
References
- 1González-Grande R, Jiménez-Pérez M, González Arjona C, Mostazo Torres J. New approaches in the treatment of hepatitis C. World J Gastroenterol 2016; 22: 1421.
- 2 European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C. J Hepatol 2015; 63: 199.
- 3Yan FM, Chen AS, Hao F, et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol 2000; 6: 805.
- 4 Ministry of health, social services and equality office of the secretary for health and consumer affairs strategic plan for tackling hepatitis in the Spanish national health system. https://www.msssi.gob.es/hepatitisC/PlanEstrategicoHEPATITI. Last access October 2017.
- 5Cruzado JM, Gil-Vernet S, Castellote J, Bestard O, Melilli E, Grinyo JM. Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient. Am J Transplant 2013; 13: 2773.
- 6Rozental R, Bicans J, Shevelev V, Trushkov S, Amerika D. Kidney transplantation from hepatitis C virus positive donors. Transplant Proc 2002; 34: 2581.
- 7Verma S, Iden K, Shimizu S, et al. Kidney transplantation from an anti-hepatitis C virus antibody-positive donor into an antihepatitis C virus antibody-negative recipient: a case report. Transplant Rep 2016; 1: 4.
10.1016/j.tpr.2016.05.001 Google Scholar
- 8Welker MW, Zeuzem S. Occult hepatitis C: how convincing are the current data? Hepatology 2009; 49: 2128.
